REVELATION BIOSCIENCES, INC. Retained Earnings
REVELATION BIOSCIENCES, INC. (REVB) had Retained Earnings of -$55.75 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$55.75M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$52.43M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$49.42M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$46.91M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$55.75M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$52.43M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | -$49.42M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$46.91M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$45.00M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | -$42.56M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$40.51M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$38.78M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | -$36.54M 10-Q/A · filed 2024-09-23 | |
| 2024-03-31 | -$28.15M 10-Q/A · filed 2024-09-23 | |
| 2023-12-31 | -$25.47M 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$23.26M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$20.64M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | -$19.19M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | -$25.35M 10-K/A · filed 2024-09-23 | |
| 2022-09-30 | -$24.14M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$22.97M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$21.13M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$14.52M 10-K · filed 2023-03-30 | -$7.82M 10-K · filed 2022-04-15 |
| 2021-09-30 | -$6.60M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | -$5.85M 10-Q · filed 2021-08-23 | |
| 2021-03-31 | -$4.52M 10-Q · filed 2021-06-22 | |
| 2020-12-31 | -$5.69M 10-K · filed 2022-04-15 | -$140.05K 10-K · filed 2021-03-31 |
| 2020-09-30 | -$12.19K 10-Q · filed 2020-11-16 | |
| 2019-12-31 | -$3.64K 10-K/A · filed 2021-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |